Doxorubicin, mesenchymal stem cell toxicity and antitumour activity: implications for clinical use

Publisher: John Wiley & Sons Inc

E-ISSN: 2042-7158|70|3|320-327

ISSN: 0022-3573

Source: JOURNAL OF PHARMACY AND PHARMACOLOGY: AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCE, Vol.70, Iss.3, 2018-03, pp. : 320-327

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract